Evidence is evidence: an interview with Mary-Claire King. Interviewed by Jane Gitschier.

by Mary-Claire King
Published 2013-01-01

Pharmaceutical procurement among public sector procurers in CARICOM

by Charles Preston, Claire King, Maryam Hinds, Francis Burnett, Rian Marie Extavour
Published 2021-05-01

A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1.

by Karen M Chisholm, Sarah D Aubert, Krister P Freese, Virginia A Zakian, Mary-Claire King, Piri L Welcsh
Published 2012-01-01

Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.

by Weston R Bodily, Brian H Shirts, Tom Walsh, Suleyman Gulsuner, Mary-Claire King, Alyssa Parker, Moom Roosan, Stephen R Piccolo
Published 2020-01-01

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study

by Tom Walsh, Suleyman Gulsuner, Ming K. Lee, Melissa A. Troester, Andrew F. Olshan, H. Shelton Earp, Charles M. Perou, Mary-Claire King
Published 2021-01-01

Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures

by Weston R. Bodily, Brian H. Shirts, Tom Walsh, Suleyman Gulsuner, Mary-Claire King, Alyssa Parker, Moom Roosan, Stephen R. Piccolo, Alvaro Galli
Published 2020-01-01

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer

by Maitri Kalra, Yan Tong, David R. Jones, Tom Walsh, Michael A. Danso, Cynthia X. Ma, Paula Silverman, Mary-Claire King, Sunil S. Badve, Susan M. Perkins, Kathy D. Miller
Published 2021-03-01